Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.61
+0.03001.90%
Post-market: 1.650.0364+2.26%19:55 EDT
Volume:978.39K
Turnover:1.54M
Market Cap:111.24M
PE:-0.89
High:1.62
Open:1.59
Low:1.53
Close:1.58
52wk High:2.98
52wk Low:1.30
Shares:69.09M
Float Shares:66.44M
Volume Ratio:1.28
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8117
EPS(LYR):-1.8117
ROE:-183.47%
ROA:-57.88%
PB:4.62
PE(LYR):-0.89

Loading ...

Inovio Pharmaceuticals: Expect to Receive File Acceptance by Year End 2025 for Ino-3107

THOMSON REUTERS
·
Nov 11, 2025

Inovio Pharmaceuticals: Potential Pdufa Date in Mid-2026 IF Priority Review Request Granted for Ino-3107

THOMSON REUTERS
·
Nov 11, 2025

Inovio Pharmaceuticals Q3 EPS $(0.87) Misses $(0.42) Estimate

Benzinga
·
Nov 11, 2025

Inovio Pharmaceuticals Inc. Stock Slides 5.8%, Underperforms Peers

Dow Jones
·
Nov 08, 2025

Inovio Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Nov 05, 2025

Inovio Pharmaceuticals Inc. Stock Rises 6.4%, Outperforms Peers

Dow Jones
·
Nov 04, 2025

Inovio completes rolling submission of BLA for INO-3107

TIPRANKS
·
Nov 03, 2025

Inovio Pharmaceuticals Inc - Expect File Acceptance by Year End 2025, Pdufa Mid-2026

THOMSON REUTERS
·
Nov 03, 2025

Inovio Completes Rolling Bla Submission Seeking Accelerated Approval for Ino-3107 as a Treatment for Rrp in Adults

THOMSON REUTERS
·
Nov 03, 2025

Inovio Grants Stock Options to New Hire Under Inducement Plan

Reuters
·
Nov 01, 2025

Press Release: INOVIO Reports Inducement Grant Under Inducement Plan

Dow Jones
·
Nov 01, 2025

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Oct 31, 2025

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 29, 2025

Inovio Pharmaceuticals Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
Oct 28, 2025

Inovio Pharmaceuticals Inc. Stock Advances 3.6%, Outperforms Peers

Dow Jones
·
Oct 25, 2025

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 23, 2025

Inovio Pharmaceuticals Inc. Stock Slides 5.7%, Underperforms Peers

Dow Jones
·
Oct 22, 2025

Inovio Reports Positive Phase 1 Results for DNA-Encoded Monoclonal Antibodies Against COVID-19

Reuters
·
Oct 21, 2025

Inovio Pharmaceuticals Inc. Stock Rallies 5.1%, Outperforms Market

Dow Jones
·
Oct 21, 2025